Grifols has publicly rejected claims about its accounting methods and the reliability of its financial disclosures. The company pointed to a report from Gotham City Research that labeled Grifols as highly leveraged and suggested manipulation of reported debt. The executive team affirmed their confidence in the precision and clarity of the company’s financial reporting, noting that the statements were submitted to the National Securities Market Commission as part of the ongoing regulatory process. The emphasis remained on accuracy and full disclosure in every financial entry and reporting period, reflecting Grifols’ status as a listed company and its obligations to investors and regulators alike.
“As a company that prioritizes transparency, integrity, and ethical conduct, we categorically reject any accusations concerning our accounting practices or any claims of inaccurate information in our consolidated financial statements”, the firm stated to the National Securities Market Commission. The message underscored the organization’s commitment to maintaining open channels with regulators and investors, reinforcing governance practices that align with global best practices.
Grifols also acknowledged ongoing discussions around perceived inaccuracies and speculative commentary from Gotham City Research. The company reiterated that, as a publicly traded entity, it provides comprehensive reporting on all transactions and maintains high levels of integrity and transparency. Management stressed that the consolidated financial statements present a true and fair view of the company’s financial position, supported by ongoing oversight from independent auditors.
Grifols: Debt reduction efforts face a hurdle above 9.5 billion
In recent statements, Grifols noted that related-party transactions and disclosures highlighted by Gotham City Research have been fully disclosed and audited since 2018, with regular reporting to the Spanish market regulator. The firm argued that such disclosures are essential to maintaining investor confidence and regulatory compliance, and they are reviewed within the framework of independent audits.
The company stressed that its consolidated financial statements rely on a strong system of internal controls over financial reporting. These safeguards are reinforced through annual audits conducted by one of the global Big Four firms, which consistently issue unqualified opinions when evaluating the company’s financial statements. The reassurance provided by these audits is presented as evidence of the soundness of Grifols’ reporting framework and the reliability of its financial data.
As a major global healthcare company, Grifols reaffirmed its unwavering commitment to the highest standards of corporate governance and financial integrity. Leadership stressed that governance remains a central priority, guiding all accounting practices and public disclosures. The firm reiterated its dedication to maintaining rigorous standards in financial reporting while upholding transparent and ethical business practices across its operations.
Observers note that the regulatory dialogue and external analyses do not alter the underlying health signals that Grifols monitors through planning and risk management processes. The company continues to provide investors with timely updates and clear explanations of any material changes in debt levels, liquidity, or capital allocation. This ongoing communication aims to balance investor needs with the rigorous expectations of global regulators, auditors, and market participants, ensuring that market participants can assess Grifols on the basis of verified information and consistent governance practices.
In summary, Grifols maintains that its governance structure, internal control environment, and audit process uphold the integrity of its financial reporting. The company asserts that its actions reflect a true and fair view of its consolidated financial statements, supported by independent assurance and ongoing regulatory engagement. Stakeholders are urged to evaluate the company’s disclosures in the context of its long-standing commitment to ethical conduct, transparency, and responsible financial management.
Attribution: Gotham City Research reporting and regulatory disclosures cited in market communications; regulatory oversight from the CNMV and the ongoing audit framework provided by a leading multinational audit firm. These sources shape the public record on Grifols’ financial disclosures and governance practices.